echocardiography. A 12-lead electrocardiogram of clinical VT was available for all patients. Clinical characteristics of 46 patients (42 men, 04 women ) are summarized in Table 1 . The mean (±SD) age of patients was 20±05 years (range, 16-36). In 45 patients, VT had a right bundle branch block with left axis deviation, and in 01 patients a right bundle branch block morphology with right axis deviation.. The mean cycle length of clinical VT was 328±22 ms (range, 280-360). Before ablation, all patients were treated by various antiarrhythmic drugs, including beta blockers (n=18), amidarone (n=16), sotalol (n=10), and calcium antagonists (n=2).
Electrophysiological Study All patients gave their written informed consent to be included in electrophysiological study and undergo radiofrequency catheter ablation. Patients were kept fasting for at least 6 hours prior to the procedure. Antiarrhythmic drugs were discontinued for at least five half-lives of the drug. Peripheral intravenous access was obtained before the patient arrived at the EP laboratory. On arrival to the EP laboratory patient was placed on the fluoroscopy table and surface electrodes were attached for acquisition of 12 lead ECG through the electrophysiology recording system. Oxygen saturation was monitored continuously using pulse oximetry and blood pressure was monitored noninvasively every 5 minutes or more frequently in necessary. An external defibrillator was available in the room and in selected patients defibrillation pad was placed. Grounding pad for radiofrequency ablation was placed in the back once a decision for radiofrequency ablation was made. Procedure was performed under conscious sedation. Patient was prepped and draped using routine sterile technique prior to obtaining venous access. Four quadripolar electrode catheters were introduced percutaneously through the femoral veins and artery, and positioned in the right atrium, at the Hiss bundle area, right ventricular apex, and right ventricular outflow tract.After the ablation the catheters and sheaths were removed and hemostasis was achieved by manual compression. Patients were transferred to telemetry unit for monitoring. 12 lead ECG was performed next day and patients were discharged home.
Equipments
Recording system-A multi-channel data acquisition system manufactured by Bard Electrophysiology, C.R. Bard Inc, USA was used for data recording. The system consisted of an amplifier for acquiring and processing surface ECG and intracardiac signals, multi-channel display screens and a computer hard drive to store the ECG and intracardiac signals. The amplifier filtered the intracardiac signals between 30 and 500 Hz. The amplifier was connected to the patient via a junction box. The signals acquired by the amplifier were displayed on two monitors one of which was real time. For most studies 4 surface and 8 to 10 intracardiac signals were displayed simultaneously. However, the computer stored simultaneous 12 lead ECG and multiple intracardiac signals. The intracardiac signals could be viewed real time at speeds up to 200 mm/sec. In addition they could also be displayed later on for review. Selected segments of the recording could be printed in a laser printer.
Stimulator -A physiological cardiac stimulator manufactured by Micropace Ltd, Australia was used during the procedures. It is an electrically isolated unit is capable of delivering constant current pacing impulses. It is computerized and can be controlled from s keyboard. It is capable of simultaneous multiple chamber pacing and can deliver stimulus at different protocols such as rapid pacing, extrastimuli and burst pacing. The stimulation threshold was set at twice the measured diastolic threshold for each location.
Radiofrequency Ablation Generator: A radiofrequency ablation generator manufactured by Boston Scientific, USA, model EPT-1000 XP was used for ablation. This unit is capable of monitoring temperature, power and impedance during radiofrequency current application. It is capable of titrating the power automatically to maintain the desired temperature at the catheter tip. It was connected to intracardiac ablation catheter via a junction box and the radiofrequency current was delivered between the catheter tip and an external grounding pad placed on the back of the patient.
Programmed Electrical Stimulation Programmed ventricular stimulation was performed at three cycle lengths (500, 400, and 350 ms), with 1-3 extrastimuli in two different sites of right ventricle( RV apex, and base or RVOT) at twice diastolic was used to induce VT. When sustained VT was not induced at the right ventricular apex, stimulation protocol was repeated at the right ventricular outflow tract, with isoproterenol administered when necessary at infusionrate of 1-3 µg/min.
Radiofequency Catheter Ablation
After the baseline electrophysiological study, a quadripolar 7 French 4 mm deflectable standard catheter (EP Technology, Boston Scientific, USA)) with 2 mm interelectrode spacing was introduced in the left ventricle for ablation. The site of VT origin (ablation site) was determined by endocardial activation mapping and pace mapping. The mechanism for idiopathic left ventricular tachycardia is probably reentry, originating in the posterior Purkinje fiber network located in the apicoseptal portion of the left ventricle or midinferior septum . The target for ablation in idiopathic left ventricular tachycardia was often best defined as site with the earliest local electrogram and identification of an abnormal retrograde Purkinje potential (Fig, 4,5) .
A radiofrequency ablation generator manufactured by Boston Scientific, USA, model EPT-1000 XP was used for temperature-guided radiofrequency ablation of the presumed site of VT origin. Actual power output, impedance, energy delivery, and catheter tip temperature were continuously monitored and displayed via an interface on a personal computer. Power output of 50 W was adjusted by use of the generator to reach and maintain the preselected temperature of 65oC for 60 seconds. In the area where VT terminated (Fig.6) , RF current was applied for several times during sinus rhythm to elongate the lesion. Thirty minutes after ablation, the same VT induction protocol as at baseline examination was repeated. The procedure was considered successful if no sustained VT, nonsustained VT, or premature ventricular beats similar in configuration to clinical arrhythmia were induced or observed. After ablation, cardiac rhythm was monitored for 48 h, and control echocardiography was performed in all the patients.
Follow-up All patients were checked up at our department every six months for medical history, physical examination, and 12-lead electrocardiogram.
Statistical Analysis
Data were expressed as mean±standard deviation, and the differences were assessed by Student's ttest. P values <0.05 were considered significant.
Results:
Electrophysiological studies and radiofrequency ablation were performed in 46 consecutive patients (42 men,04 women), age ranging from 16 to 36 years (mean 20±5 years) with verapamil-sensitive ILVT and structurally normal hearts.Clinical VT can be induced by programed ventricular stimulation, or by isoproterenol infusion in 43 of 46 patients (Table 3) . No other clinical forms of VT were provoked in any of the patients. Clinical characteristics of 46 patients (42 men, 04 women ) are summarized in Table 1 . Radiofrequency catheter ablation was successful in all 46 patients after delivering 6±2 (range, 2-9) radiofrequency pulses( Table 5 ). VT originating in the left ventricle had an mid posteroseptal site in 44 patients and an inferoposterior septal site in two patients. All patients, Purkinje potential was recorded preceding the beginning of the QRS of VT (Fig. 4,5 ). All these patients were successfully ablated after delivery of radiofrequency pulses. At the time of VT elimination, the mean catheter tip temperature measured 62±6°C (range, 60-64.There were no immediate complications of ablative procedure in any of the patients, irrespective of the site of VT origins. Before the ablation, the mean left ventricular ejection fraction was 64±5% (range, 57-70%). During the mean follow-up period of 03 years, none of the patients developed ventricular dysfunction or new form of VT as a consequence of ablation. The recurrence of clinical VT was observed in 2 patients. 
Discussion
The first report of fascicular ventricular tachycardia was in 1979 by Zipes et all; they described a ventricular tachycardia (VT) of right bundle branch block morphology with left axis deviation and a relatively narrow QRS width (Fig  01) 10 . At present this tachycardia is well characterized as one presenting as exercise related VT in the age group of 15 to 40 years and predominantly in males (60% to 80%) 10 . Fascicular VT occurs in patients with no structural cardiac abnormality and is usually paroxysmal, but it can occasionally be incessant in nature resulting in tachycardiomyopathy. While termination by calcium channel blockers is the hallmark of this tachycardia, catheter ablation is very effective in the cure of this tachycardia [11] [12] . Intravenous verapamil is effective in terminating the tachycardia. However the efficacy of oral verapamil in preventing tachycardia relapse is variable.
Though fascicular tachycardias do not generally respond to adenosine, termination of VT originating from the left anterior fascicle by intravenous adenosine has been documented. Different approaches for radiofrequency ablation have been described by various authors. Nakagawa et al preferred careful localization of the Purkinje potential in guiding ablation 13 . They selected the area where a Purkinje potential precedes the QRS complex during tachycardia. Nogami et al. recommend pace mapping with a match between the 12 simultaneously recorded ECG leads during pacing and the clinical tachycardia for localizing the site of ablation 14 . They hypothesize that pathways within the Purkinje network that are not included in the reentry circuit responsible for the tachycardia may also become activated. Ablation of those regions may not result in interruption of the tachycardia circuit. Since fascicular VT is sometimes difficult to induce despite pharmacological provocation, some workers prefer primary ablation. In a recent report, seven cases of incessant fascicular VT were successfully ablated with no recurrence. They reported a shorter procedure time, significantly lower fluoroscopy time and lesser number of radiofrequency energy deliveries in the primary versus elective groups. The longer procedural time during elective ablation was mainly due to the time spent in induction of fascicular VT 15 . Results of our study is similar to other studies described above. Recurrence rate is lower than that described in other studies.
Study Limitations
This is an observational, nonrandomized trial reporting the efficacy of RF ablation in patients with drug refractory ILVT. Furthermore, the antiarrhythmic drug regimen was nonuniform but reflects routine daily practice. Although all inducible VTs were targeted, this study was limited to patients who tolerated tachycardia for a prolonged period. Although the outcome of this study with routine clinical practice, it is important to note that RFCA procedures in patients with drug refractory VT are complex ,time consuming, and uncomfortable for patients.
Conclusion
Idiopathic left ventricle tachycardia occurs most commonly in young population. It is a unique clinical entity, characterized by RBBB and left/ superior axis morphology without structurally heart disease. Prompt recognition of this arrhythmia is important since specific treatment will terminate the VT. Prognosis is excellent, with high cure rate after radiofrequency catheter ablation
